Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

NewLink Genetics Corp (NASDAQ:NLNK)

11.14
Delayed Data
As of Dec 09
 +0.13 / +1.18%
Today’s Change
9.23
Today|||52-Week Range
37.65
-69.39%
Year-to-Date
Inovio Pharmaceuticals, Inc.'s Biggest Win in 2016
Dec 09 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close11.01
Today’s open11.13
Day’s range11.04 - 11.47
Volume173,611
Average volume (3 months)285,736
Market cap$324.6M
Dividend yield--
Data as of 4:00pm ET, 12/09/2016

Growth & Valuation

Earnings growth (last year)-142.47%
Earnings growth (this year)-119.15%
Earnings growth (next 5 years)--
Revenue growth (last year)-60.31%
P/E ratioNM
Price/Sales15.19
Price/Book1.64

Competitors

 Today’s
change
Today’s
% change
ARLZAralez Pharmaceutica...+0.14+2.83%
AKBAAkebia Therapeutics ...+0.05+0.59%
SRNESorrento Therapeutic...-0.05-0.92%
MNKDMannKind Corp-0.00-0.09%
Data as of 4:00pm ET, 12/09/2016

Financials

Next reporting dateMarch 2, 2017
EPS forecast (this quarter)-$0.62
Annual revenue (last year)$68.5M
Annual profit (last year)-$40.4M
Net profit margin-58.95%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Executive &
Scientific Officer
Charles J. Link
President, Director &
Chief Medical Officer
Nicholas N. Vahanian
Corporate headquarters
Ames, Iowa

Forecasts


Search for Jobs